| Polycythemia Vera |
1 |
1 |
| Genomic Medicine |
0 |
1 |
| Biologic Therapy |
0 |
0.73 |
| Targeted Cancer Therapy |
0 |
0.53 |
| Leukemia |
0 |
0.42 |
| Polycythemia |
0 |
0.42 |
| Chronic Lymphocytic Leukemia |
0 |
0.37 |
| Chronic Myeloid Leukemia |
0 |
0.37 |
| Neoplasm |
0 |
0.32 |
| Tyrosine Kinase Inhibitor |
0 |
0.29 |
| Antineoplastic Drug |
0 |
0.21 |
| Prognosis |
0 |
0.21 |
| Remission |
0 |
0.21 |
| Bone Marrow |
0 |
0.15 |
| Essential Thrombocytosis |
0 |
0.15 |
| Adherence |
0 |
0.11 |
| Biomarker |
0 |
0.11 |
| Bone |
0 |
0.11 |
| Clinical Research |
0 |
0.11 |
| Disease Management |
0 |
0.11 |
| Epigenetics |
0 |
0.11 |
| Pathogenesis |
0 |
0.11 |
| Thrombocytosis |
0 |
0.11 |
| Tyrosine Kinase |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Myelofibrosis |
0 |
0.1 |